NEW YORK, Oct. 3, 2011 /PRNewswire/ -- PLC Medical Systems, Inc. (OTC: PLCSF) today announced that Mark Tauscher, CEO, will present at RetailInvestorConferences.com. DATE:
October 6, 2011TIME:
11:00 AM EDTLINK:
www.retailinvestorconferences.com > Click the red "register/ watch event now" button.This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available at the above link as well as on the company's investor relations website (www.plcmed.com, follow links for investors) for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
About PLC Systems Inc.:PLC Systems Inc.,
headquartered in Milford, Mass., is a medical device company
focused on innovative technologies for the cardiac and vascular
markets. PLC's newest product, RenalGuard®, has been developed
to help prevent the onset of contrast induced nephropathy(CIN) in
at-risk patients undergoing certain imaging procedures. It is
already approved for sale in the EU for general fluid balancing.
Two investigator-sponsored European studies have demonstrated
RenalGuard's effectiveness at preventing CIN. RenalGuard is being
studied in a pivotal trial in the U.S., as required for approval by
FDA. The RenalGuard System™ consists of a closed loop,
software-controlled console and single-use sets that physicians and
nurses use for automated matched fluid replacement to minimize
over- or under-hydration of patients during medical procedures
where creating and maintaining high urine outputs is beneficial.
For more information, visit our website at http://w